Armata Pharmaceuticals (ARMP) Gains from Investment Securities (2013 - 2026)
Armata Pharmaceuticals' (ARMP) quarterly Gains from Investment Securities came in at $769.0 in Q1 2026, down 94.51% year-on-year from $14000.0 in Q1 2025, and down 99.95% quarter-over-quarter from $1.6 million in Q3 2025.
Armata Pharmaceuticals (ARMP) Gains from Investment Securities (2013 - 2026) Analysis & Trends
Armata Pharmaceuticals has disclosed Gains from Investment Securities across 13 years of filings, most recently posting $769.0 for Q1 2026.
- Gains from Investment Securities for Q1 2026 came in at $769.0, down 94.51% year-over-year; the trailing twelve-month figure through Mar 2026 was $769.0 (down 99.99% YoY), and the FY2025 annual result was $346500.0, down 71.85% from the prior year.
- Gains from Investment Securities came in at $769.0 for Q1 2026 at Armata Pharmaceuticals, down from $1.6 million in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $8.6 million in Q4 2022 to a low of -$916000.0 in Q4 2024.
- The 5-year median for Gains from Investment Securities is $141786.0 (2022), against an average of $971462.1.
- Peak annual rise in Gains from Investment Securities reached 36503.49% in 2024, while the deepest fall reached 1626.67% in 2024.
- Armata Pharmaceuticals' Gains from Investment Securities stood at $8.6 million in 2022, then tumbled by 99.3% to $60000.0 in 2023, then sank by 1626.67% to -$916000.0 in 2024, then jumped by 274.24% to $1.6 million in 2025, then plunged by 99.95% to $769.0 in 2026.
- The last three Gains from Investment Securities figures came in at $769.0 (Q1 2026), $1.6 million (Q3 2025), and $1.6 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - |
| 10 | Armata Pharmaceuticals | 275.44 Mn | 270.68 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 769.00 |
| Mar 31, 2026 | 769.00 |
| Sep 30, 2025 | 1.60 Mn |
| Sep 30, 2025 | 1.60 Mn |
| Jun 30, 2025 | 1.60 Mn |
| Jun 30, 2025 | 1.60 Mn |
| Mar 31, 2025 | 14,000.00 |
| Mar 31, 2025 | 14,000.00 |
| Dec 31, 2024 | -916,000.00 |
| Dec 31, 2024 | -916,000.00 |
| Sep 30, 2024 | 977,257.00 |
| Sep 30, 2024 | 977,257.00 |
| Jun 30, 2024 | 266,251.00 |
| Jun 30, 2024 | 266,251.00 |
| Mar 31, 2024 | 1.78 Mn |
| Mar 31, 2024 | 1.78 Mn |
| Dec 31, 2023 | 60,000.00 |
| Dec 31, 2023 | 60,000.00 |
| Sep 30, 2023 | 17,500.00 |
| Sep 30, 2023 | 17,500.00 |